Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Mentor Worldwide, LLC

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Mentor Worldwide, LLC

Regulatory records
17
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 17 FDA records to the applicant name Mentor Worldwide, LLC. It includes 2 original PMA approvals. 2 entries are PMA supplements. 13 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from May 10, 2000 to Oct 23, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code FWM appears in 9 of the 17 linked filings. The collection spans 2 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P990075, with 9 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 5 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 33 Technology Dr., Irvin, CA, 92618. Recorded on P990075/S071, decision dated Oct 23, 2026.

Changes described in PMA records

P990075/S071: Saline-Filled and Spectrum Breast Implants

This 30-Day Notice for Mentor Worldwide, LLC describes a process change on existing packaging equipment for saline-filled and Spectrum breast implants. The stated change is the addition of small size packaging tooling on the existing packaging equipment.

The record does not state which package sizes, tooling dimensions, production lines, or validation activities are involved. The notice is a supplement to PMA P990075, not a new approval of the device system, and the stated purpose is not independent proof of safety or clinical effectiveness.

FDA approval-order wording

the addition of small size packaging tooling on the existing packaging equipment

Oct 23, 2026 · 30-Day Notice

P060028/S063: MemoryShape Breast Implants

This 30-Day Notice for the MemoryShape Breast Implants supplement records a process change limited to packaging equipment. The stated change is the addition of small size packaging tooling on the existing packaging equipment.

The record does not describe any change to the implant itself, its materials, labeling, indications, or clinical data. Specific information about the tooling design, affected package sizes, validation results, or implementation timing is absent from the supplied fields. The notice is tied to the original PMA identifier but does not constitute a new approval of the device system.

FDA approval-order wording

the addition of small size packaging tooling on the existing packaging equipment

Oct 23, 2026 · 30-Day Notice

P990075/S070: MENTOR CORPORATION SALINE-FILLED AND SPECTRUM (R) MAMMARY PROSTHESES

The FDA recorded decision OK30 on 2026-10-21 for P990075/S070, a 30-Day Notice supplement to Mentor Worldwide, LLC's saline-filled mammary prosthesis line, titled MENTOR CORPORATION SALINE-FILLED AND SPECTRUM (R) MAMMARY PROSTHESES. The device category is an inflatable internal breast prosthesis under product code FWM, listed in the general and plastic surgery specialty. The supplement reason is recorded as a process change affecting manufacturer, sterilizer, packager or supplier.

The recorded change is a shift from quarterly to annual B/F testing, as stated in the source record. This is a supplement-level decision on that testing schedule, not a new approval of the underlying prosthesis system. The source does not define B/F testing, identify which manufacturing site is affected, or provide the supplement's review documents, so the technical scope and any conditions of the decision remain unknown.

FDA approval-order wording

Approved change from quarterly to annual B/F testing.

Oct 21, 2026 · 30-Day Notice

P060028/S058: MENTOR MemoryShape Breast Implants

FDA’s recorded scope: For introduction of an Overall Compliance Rate in addition to the existing FDA-defined target rate and Introduction of a Call Center to assist patient troubleshooting concerns

Jul 21, 2026 · Normal 180 Day Track No User Fee

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Mentor Worldwide, LLCPMA supplementOct 23, 2026FDA
Mentor Worldwide, LLCPMA supplementOct 23, 2026FDA
Mentor Worldwide, LLCPMA supplementOct 21, 2026FDA
Mentor Worldwide, LLCPMA supplementJul 21, 2026FDA
Mentor Worldwide, LLCPMA supplementMay 12, 2026FDA
Mentor Worldwide, LLCPMA supplementFeb 4, 2026FDA
Mentor Worldwide, LLCPMA supplementFeb 4, 2026FDA
Mentor Worldwide, LLCPMA supplementJan 2, 2026FDA
Mentor Worldwide, LLCPMA supplementDec 17, 2025FDA
Mentor Worldwide, LLCPMA supplementDec 17, 2025FDA
Mentor Worldwide, LLCPMA supplementNov 18, 2025FDA
Mentor Worldwide, LLCPMA supplementAug 12, 2025FDA
Mentor Worldwide, LLCPMA supplementAug 12, 2025FDA
Mentor Worldwide, LLCPMA supplementAug 8, 2025FDA
Mentor Worldwide, LLCPMA supplementAug 8, 2025FDA
Mentor Worldwide, LLCPMA approvalJun 14, 2013FDA
Mentor Worldwide, LLCPMA approvalMay 10, 2000FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.